Former Junshi Biosciences CCO Qian Wei Returns to Roche as General Manager of Oncology Business Unit in China

It is reported that Qian Wei will be appointed as the General Manager of Roche Pharmaceuticals China Customer Interaction Business Model - Oncology Field, starting from February 22, 2022.

Previously, on November 3, 2021, Junshi Biosciences issued an internal announcement stating that Chief Commercial Officer (CCO) Wei Qian had resigned for personal development reasons, with the last working day being November 12.

Notably, before joining Junshi Biosciences, Qian Wei served as the General Manager of the First Business Unit and the Acting Head of the General and Specialty Medicine Business Unit at Roche.From September 2007 to September 2016, served as Oncology Marketing Manager, and VP of the Gastrointestinal, Anesthesia, and Anti-Infective Business Unit (GAA BU) at AstraZeneca.